Dr. Squillacote is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Spruce Place
Glen Rock, NJ 07452Phone+1 201-665-3723
Education & Training
University of Miami/Jackson Health SystemResidency, Neurology, 1987 - 1989- University of Miami/Jackson Health SystemResidency, Internal Medicine, 1986 - 1987
University of Miami Leonard M. Miller School of MedicineClass of 1986
Certifications & Licensure
FL State Medical License 1987 - 2019
Clinical Trials
- A Pharmacokinetic Study to Assess Dose Proportionality, Safety and Tolerability of Diazepam Nasal Spray in Healthy Adult Volunteers Start of enrollment: 2016 Jan 01
Publications & Presentations
PubMed
- 87 citationsLong-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: Results from phase III extension study 307Gregory L. Krauss, Emilio Perucca, Elinor Ben-Menachem, Patrick Kwan, Jerry J. Shih
Epilepsia. 2014-07-01 - 337 citationsAdjunctive perampanel for refractory partial-onset seizures: Randomized phase III study 304Jacqueline A. French, Gregory L. Krauss, Victor Biton, David Squillacote, Haichen Yang
Neurology. 2012-08-07 - 43 citationsPerampanel, an AMPA antagonist, found to have no benefit in reducing “off” time in Parkinson's disease†‡§Andrew J. Lees, Stanley Fahn, Karla Eggert, Joseph Jankovic, Anthony E. Lang
Movement Disorders. 2012-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
